Ohio State University Comprehensive Cancer Center
Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-09-02
- Target Recruit Count
- 56
- Registration Number
- NCT00201708
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-12-06
- Target Recruit Count
- 6
- Registration Number
- NCT00201669
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2018-07-26
- Target Recruit Count
- 40
- Registration Number
- NCT00201864
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-12-06
- Target Recruit Count
- 27
- Registration Number
- NCT00201812
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-11-30
- Target Recruit Count
- 38
- Registration Number
- NCT00201838
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2015-06-10
- Target Recruit Count
- 12
- Registration Number
- NCT00201695
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Conditions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2017-02-08
- Target Recruit Count
- 8
- Registration Number
- NCT00143065
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Conditions
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2013-05-03
- Target Recruit Count
- 30
- Registration Number
- NCT00124644
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
- Conditions
- Locations
- 🇺🇸
Central Baptist Hospital, Lexington, Kentucky, United States
🇺🇸Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
🇺🇸Grant/Riverside Methodist Hospitals, Columbus, Ohio, United States
SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors
- Conditions
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States